Arie Belldegrun's Net Worth
$6.86 Million
Who is Arie Belldegrun?
Arie Belldegrun has an estimated net worth of $6.86 Million. This is based on reported shares across multiple companies, which include Allogene Therapeutics, Inc., Cougar Biotechnology, Inc., Paramount Acquisition Corp, Kronos Bio, Inc., Ginkgo Bioworks Holdings, Inc., UroGen Pharma Ltd., Kite Pharma, Inc., Nile Therapeutics, Inc., Hana Biosciences Inc, and Arno Therapeutics, Inc.
SEC CIK
Arie Belldegrun's CIK is 0001296549
Past Insider Trading and Trends
2006 was Arie Belldegrun's most active year for acquiring shares with 10 total transactions. Arie Belldegrun's most active month to acquire stocks was the month of May. 2009 was Arie Belldegrun's most active year for disposing of shares, totalling 9 transactions. Arie Belldegrun's most active month to dispose stocks was the month of June. 2021 saw Arie Belldegrun paying a total of $6,938,992.52 for 669,006 shares, this is the most they've acquired in one year. In 2017 Arie Belldegrun cashed out on 585,107 shares for a total of $22,103,372.18, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Allogene Therapeutics, Inc. (ALLO) Snapshot price: $2.39
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,060.80% | 2.07M |
$2.90 | $5,999,998.50 | 2.26M |
May 16
| |||
Form 4
| +12.81% | 211.97K |
—
|
—
| 1.87M |
Jan 25
| |||
Form 4
| +344.97% | 1.28M |
—
|
—
| 1.65M |
Mar 22
| |||
Form 4/A
|
—
|
0
|
—
|
—
| 4.71M |
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
| 4.71M |
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 4
| +387.60% | 155.04K |
$12.60 | $1,953,491.40 | 195.04K |
Jan 12
| |||
Form 4
| +185.85% | 379.07K |
$18.22 | $6,906,582.52 | 583.03K |
May 24
| |||
Form 4
| +35.68% | 53.63K |
—
|
—
| 203.97K |
Mar 26
| |||
Form 4
| +8.65% | 146.38K |
$47.00 | $6,879,954.00 | 1.84M |
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 18
| |||
Form 4
| -9.94% | -585.52K |
—
|
—
| 5.31M |
Scheduled
|
May 13
| ||
Form 4
| -9.04% | -585.52K |
—
|
—
| 5.89M |
Scheduled
|
Apr 26
| ||
Form 4
| +329.52% | 115.33K |
—
|
—
| 150.33K |
Mar 13
| |||
Form 4/A
| +12.99% | 194.44K |
$18.00 | $3,500,010.00 | 1.69M |
Oct 15
| |||
Form 4
| +214.81% | 7.66M |
$18.00 | $630,000.00 | 11.23M |
Oct 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cougar Biotechnology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -357.33K |
$43.00 | -$15,365,276.00 |
0
|
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| +8.38% | 5K |
$27.00 | $134,997.00 | 64.66K |
Feb 21
| |||
Form 4
| +33.58% | 15K |
$30.50 | $457,500.00 | 59.66K |
Dec 18
| |||
Form 4
| +9.03% | 3.7K |
$23.90 | $88,430.00 | 44.66K |
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
| +20.97% | 7.1K |
$21.10 | $149,810.00 | 40.96K |
May 8
| |||
Form 4
| +79.52% | 15K |
$18.33 | $274,975.00 | 33.86K |
Feb 26 - Feb 27
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 18.86K |
—
|
—
| 18.86K |
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28 - Sep 6
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Paramount Acquisition Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17 - Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11 - Jan 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kronos Bio, Inc. (KRON) Snapshot price: $0.9601
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| +1,070.62% | 2.74M |
$16.15 |
—
| 2.99M |
Oct 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ginkgo Bioworks Holdings, Inc. (DNA) Snapshot price: $5.71
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +117.40% | 105.26K |
—
|
—
| 194.93K |
Jun 12 - Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +378.43% | 70.92K |
—
|
—
| 89.66K |
Jun 10
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||